Le Lézard
Classified in: Health, Science and technology

Global Cell Therapy Market Report 2023: Advancements in Biotechnology Drives Growth - ResearchAndMarkets.com

The "Global Cell Therapy Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.

The global cell therapy market size attained a value of USD 13.8 billion in 2022. The market is likely to grow at a CAGR of 18.10% during the forecast period of 2023-2031 to attain a value of USD 61.2 billion by 2031.

Cell therapy has emerged as a rapidly growing and innovative segment of the global healthcare industry. It encompasses a diverse range of therapeutic approaches, including regenerative medicine, immunotherapy, and gene therapy, aimed at treating various diseases and disorders by harnessing the power of living cells.

The global cell therapy market is anticipated to witness significant growth in the coming years, driven by advancements in biotechnology, increasing investment in research and development, and a rising prevalence of chronic diseases and genetic disorders.

Factors like rising incidence of cancer, cardiovascular diseases, and autoimmune disorders drive the demand for innovative and effective treatment options, are fuelling the growth of the cell therapy market. Developments in gene editing technologies, such as CRISPR/Cas9, have opened new possibilities for cell therapies, offering improved efficacy and safety profiles.

Governmental and private investments in cell therapy research have led to a robust pipeline of experimental treatments, which are expected to enter the market in the coming years.

Market Segmentation

The market can be categorized into cell type, therapy type, therapeutic area, end user, and region.

by Cell Type

by Therapy Type

by Therapeutic Area

by End User

by Region

North America


Asia Pacific

Latin America

Middle East and Africa

Key Players in the Global Cell Therapy Market

The report gives an in-depth analysis of the key players involved in the cell therapy market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

For more information about this report visit https://www.researchandmarkets.com/r/d8g48x

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

These press releases may also interest you

at 10:47
Transportation industry veteran Rick Marshall is pleased to announce the launch of USMCA Solutions Hub, a new approach to improve cross border distribution for North American companies. "If we rethink the approach and really look at how to...

at 10:40
The Kingdom of Denmark officially celebrated the in-country arrival of its first four permanently based F-35A Lightning II aircraft at Skrydstrup Air Base, Denmark....

at 10:10
In a remarkable display of innovation and dedication to audio excellence, IPRO, renowned for protecting electronics from water damage without compromising sound quality, has raised the bar with an innovative new waterproof acoustic solution that has...

at 09:50
PCS, a leading provider of 24/7 outsourced technology services and IT helpdesk support, is thrilled to announce the opening of its new office in Florida. Located in Sarasota, this expansion solidifies PCS's growing national footprint across the...

at 09:00
With the return of cold weather, EcoFlow, a portable power and eco-friendly energy solutions company, is offering its biggest discounts ever on its best-selling portable power stations for Amazon's Prime Big Deals Day sales event. Customers can save...

at 08:30
Integrated Oncology Network (ION) is implementing Fuse Oncology's (Fuse) groundbreaking product, S!GNAL, across its extensive network, following a highly successful trial that demonstrated the quantifiable value of the software. ION's S!GNAL trial...

News published on and distributed by: